C1 esterase inhibitor recombinant Intravenous and Levodopa (Oral Inhalation)
Determining the interaction of C1 esterase inhibitor recombinant Intravenous and Levodopa (Oral Inhalation) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: C1 esterase inhibitor (human)
Brand name: Berinert, Cinryze, Haegarda, Ruconest
Synonyms: Complement C1 esterase inhibitor, C1 Inhibitor (Human)
Generic Name: levodopa
Brand name: Inbrija, Dopar, Larodopa
Synonyms: Levodopa inhalation
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- C1 esterase inhibitor recombinant Intravenous-Levodopa inhalation
- C1 esterase inhibitor recombinant Intravenous-Levodopa, Carbidopa, and Entacapone
- C1 esterase inhibitor recombinant Intravenous-Levodopa/Carbidopa
- C1 esterase inhibitor recombinant Intravenous-Levofloxacin
- C1 esterase inhibitor recombinant Intravenous-Levofloxacin (Systemic)
- C1 esterase inhibitor recombinant Intravenous-Levofloxacin injection
- Levodopa (Oral Inhalation)-C1 esterase inhibitor, human Intravenous
- Levodopa (Oral Inhalation)-C1 Inhibitor (Human)
- Levodopa (Oral Inhalation)-C1 Inhibitor (Human) (Berinert)
- Levodopa (Oral Inhalation)-C1 Inhibitor (Human) (Cinryze)
- Levodopa (Oral Inhalation)-C1 Inhibitor (Human) (Haegarda)
- Levodopa (Oral Inhalation)-C1 Inhibitor (Recombinant)